Innomar Strategies

Are you aware of the recent changes to recalls and pending changes to the MDR that will impact MDEL holders? For example, changes to Shortage reporting for importers, new mandatory supplier information and updates to the MDEL Application Form. All of these changes may impact your SOPs and updates will be required. Stay Ahead of the Curve! Discover how our personalized Bi-Annual Regulatory updates will enable you to keep current and compliant with the ever-changing Canadian Medical Devices Regulations and their supporting interpretations found in Health Canada guidance and policies. Learn how we can help your organization thrive in the ever-evolving medical device landscape.

When precision, compliance, and reliability matter most, partner with Innomar Strategies. Our GMP-standard facilities and multilingual logistics experts handle importation, temperature-controlled warehousing, and distribution for all product types, from APIs to finished goods. Discover why leading life sciences companies trust us to deliver efficiency and performance at every step. Visit our site to see how Innomar supports your supply chain.

Turn your Patient Support Program data into your strongest market access advantage. In today’s Canadian biopharma landscape, payers and HTAs expect more than clinical results - they expect real-world proof of value. Without robust RWE, even innovative therapies can face barriers to coverage and adoption. Innomar helps biopharma teams harness the untapped potential of PSP data - transforming real-world insights into evidence that strengthens product value, informs access strategy, and improves patient outcomes. Our RWE specialists partner with leading biopharma and biosimilar companies across Canada to build value-driven commercialization strategies from pre-launch through maturity. Read the article or connect with our experts to start building your RWE advantage today.

Turn your Patient Support Program data into your strongest market access advantage. In today’s Canadian biopharma landscape, payers and HTAs expect more than clinical results - they expect real-world proof of value. Without robust RWE, even innovative therapies can face barriers to coverage and adoption. Innomar helps biopharma teams harness the untapped potential of PSP data - transforming real-world insights into evidence that strengthens product value, informs access strategy, and improves patient outcomes. Our RWE specialists partner with leading biopharma and biosimilar companies across Canada to build value-driven commercialization strategies from pre-launch through maturity. Read the article or connect with our experts to start building your RWE advantage today.

Your RCT data tells part of the story. Real-World Evidence tells the rest. Canadian HTAs and payers demand proof of real-world impact. Without it, access and reimbursement opportunities can stall. Leverage your Patient Support Program data with Innomar’s RWE expertise. We help biopharma teams turn existing program data into powerful insights that strengthen value demonstration, accelerate access, and improve patient outcomes. Trusted by leading biopharma and biosimilar companies across Canada, our integrated RWE solutions support brands from pre-launch to lifecycle maturity. Read the article or connect with our experts to start your RWE journey today.

Turn your Patient Support Program data into your strongest market access advantage. In today’s Canadian biopharma landscape, payers and HTAs expect more than clinical results - they expect real-world proof of value. Without robust RWE, even innovative therapies can face barriers to coverage and adoption. Innomar helps biopharma teams harness the untapped potential of PSP data - transforming real-world insights into evidence that strengthens product value, informs access strategy, and improves patient outcomes. Our RWE specialists partner with leading biopharma and biosimilar companies across Canada to build value-driven commercialization strategies from pre-launch through maturity. Read the article or connect with our experts to start building your RWE advantage today.